secwatch / observer
8-K filed March 12, 2024, 7:59 PM ET CIK 0001401395
leadership confidence high sentiment neutral materiality 0.75

Neptune Wellness appoints interim CEO and COO after departing prior CEO

Neptune Wellness Solutions Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Michael De Geus

Interim President and Chief Executive Officer
Neptune Wellness Solutions Inc.
Effective
2024-03-08
Filed
March 12, 2024, 7:59 PM ET
appointed Board member Michael De Geus as its interim President and Chief Executive Officer, and Cedrick Billequey, General Manager of the Company’s subsidiary, Biodroga Nutraceuticals, Inc. (“Biodroga”), as its Interim Chief Operating Officer
Appointed (interim)

Cedrick Billequey

Interim Chief Operating Officer
Neptune Wellness Solutions Inc.
Effective
2024-03-08
Filed
March 12, 2024, 7:59 PM ET
appointed Board member Michael De Geus as its interim President and Chief Executive Officer, and Cedrick Billequey, General Manager of the Company’s subsidiary, Biodroga Nutraceuticals, Inc. (“Biodroga”), as its Interim Chief Operating Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael De Geus was appointed as Interim President and Chief Executive Officer at Neptune Wellness Solutions Inc..

Action
appointed
Role
Interim President and Chief Executive Officer
Exact text from the filing
appointed Board member Michael De Geus as its interim President and Chief Executive Officer, and Cedrick Billequey, General Manager of the Company’s subsidiary, Biodroga Nutraceuticals, Inc. (“Biodroga”), as its Interim Chief Operating Officer
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Cedrick Billequey was appointed as Interim Chief Operating Officer at Neptune Wellness Solutions Inc..

Action
appointed
Role
Interim Chief Operating Officer
Exact text from the filing
appointed Board member Michael De Geus as its interim President and Chief Executive Officer, and Cedrick Billequey, General Manager of the Company’s subsidiary, Biodroga Nutraceuticals, Inc. (“Biodroga”), as its Interim Chief Operating Officer
View on SEC.gov
Source: SEC EDGAR
accession 0001437749-24-007460
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.